Jazz Pharmaceuticals PLC (JAZZ) — Cash Flow Reinvestment Rate
Jazz Pharmaceuticals PLC (JAZZ) has a Cash Flow Reinvestment Rate of 0.59x as of March 2026, reinvesting $239.70 Million (capex $19.70 Million plus investments $220.00 Million) from operating cash flow of $408.20 Million. See cash generation quality of Jazz Pharmaceuticals PLC to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jazz Pharmaceuticals PLC Cash Flow Reinvestment Rate (2010–2025)
Historical reinvestment intensity for Jazz Pharmaceuticals PLC across 16 annual periods. For the full cash flow conversion analysis, see JAZZ cash flow conversion.
Annual Cash Flow Reinvestment Rate for Jazz Pharmaceuticals PLC (2010–2025)
Year-by-year capital reinvestment analysis for Jazz Pharmaceuticals PLC. See Jazz Pharmaceuticals PLC free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | $529.03 Million | $1.36 Billion | $58.75 Million | ▼ -2.1% |
| 2024 | 0.40x | $556.26 Million | $1.40 Billion | $48.07 Million | ▼ -29.0% |
| 2023 | 0.56x | $613.20 Million | $1.09 Billion | $23.96 Million | ▲ +43.1% |
| 2022 | 0.39x | $499.23 Million | $1.27 Billion | $498.19 Million | ▼ -72.6% |
| 2021 | 1.43x | $1.11 Billion | $778.51 Million | $45.53 Million | ▲ +25.9% |
| 2020 | 1.14x | $1.02 Billion | $899.65 Million | $379.25 Million | ▲ +161.2% |
| 2019 | 0.43x | $337.63 Million | $776.40 Million | $182.34 Million | ▼ -21.5% |
| 2018 | 0.55x | $442.38 Million | $798.90 Million | $131.47 Million | ▲ +42.7% |
| 2017 | 0.39x | $268.95 Million | $693.09 Million | $113.95 Million | ▼ -7.2% |
| 2016 | 0.42x | $246.86 Million | $590.54 Million | $181.58 Million | ▲ +119.7% |
| 2015 | 0.19x | $101.23 Million | $531.94 Million | $35.96 Million | ▼ -74.6% |
| 2014 | 0.75x | $304.25 Million | $405.76 Million | $238.97 Million | ▲ +177.8% |
| 2013 | 0.27x | $76.55 Million | $283.62 Million | $11.28 Million | ▼ -31.4% |
| 2012 | 0.39x | $98.27 Million | $249.75 Million | $22.48 Million | ▼ -26.9% |
| 2011 | 0.54x | $81.63 Million | $151.60 Million | $5.78 Million | ▲ +570.0% |
| 2010 | 0.08x | $4.73 Million | $58.87 Million | $4.73 Million | — |